Switching from branded alendronate or risedronate to generic alendronate: Effect on persistence with bisphosphonate therapy in Germany

被引：0
|
作者：
Ziller, V. [1 ]
Schuessel, K.
Czeche, S.
Franzmann, A.
Kloeckner, D.
Quinzler, R.
Schulz, M. [2 ]
Moehrke, W. [3 ]
Hadji, P. [1 ]
机构：
[1] Univ Hosp Giessen & Marburg, Dept Gynecol, Marburg, Germany
[2] DAPI Verein Deutsch Arzneiprufungsinst eV, Eschborn, Germany
[3] Procter & Gamble Pharmaceut, Schwalbach A Ts, Germany
来源：
BONE | 2009年 / 44卷 / 02期
关键词：
D O I：
10.1016/j.bone.2009.03.423
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S449 / S450
页数：2
相关论文
共 50 条
  • [31] Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
    Mabilleau, G.
    Kwaasi, A. A. A.
    Tsoumpra, M. K.
    Sabokbar, A.
    Dunford, J. E.
    Ebetino, F. H.
    Russell, R. G. G.
    BONE, 2011, 48 : S220 - S220
  • [32] GASTRIC ULCEROGENIC AND HEALING IMPAIRMENT EFFECTS OF RISEDRONATE, A NITROGEN-CONTAINING BISPHOSPHONATE IN RATS. COMPARISON WITH ALENDRONATE AND MINODRONATE
    Amagase, K.
    Inaba, A.
    Senta, T.
    Ishikawa, Y.
    Nukui, K.
    Murakami, T.
    Takeuchi, K.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2011, 62 (06): : 609 - 618
  • [33] MONITORING COMPLIANCE AND PERSISTENCE WITH ALENDRONATE THERAPY STARTED AFTER HIP FRACTURE
    Turk, A.
    Fripp, A.
    Ahmed, S.
    Beck, S.
    Johansen, A.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S293 - S294
  • [34] Bisphosphonate withdrawal effect: A study of long-term treatment with etidronate or alendronate
    Hampson, G
    Constancio, L
    Blake, G
    Fogelman, I
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S55 - S55
  • [35] Successful treatment of multicentric reticulohistiocytosis with alendronate - Evidence for a direct effect of bisphosphonate on histiocytes
    Goto, H
    Inaba, M
    Kobayashi, K
    Imanishi, Y
    Kumeda, Y
    Inui, K
    Okada, F
    Nishizawa, Y
    ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3538 - 3541
  • [36] Lowering the risk of esophagitis from alendronate therapy
    Chase, JL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (09) : 892 - 893
  • [37] Effects of alendronate and risedronate therapy on hepatic antioxidant enzyme activity and lipid peroxidation in ovariectomized rats
    Yalin, Serap
    Comelekoglu, Ulku
    Bagis, Selda
    Berkoz, Mehmet
    Eroglu, Pelin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2010, 40 (04) : 613 - 618
  • [38] Erratum to: Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy
    R. Lindsay
    N. B. Watts
    J. L. Lange
    P. D. Delmas
    S. L. Silverman
    Osteoporosis International, 2013, 24 (8) : 2375 - 2376
  • [39] Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats
    Fuchs, Robyn K.
    Phipps, Roger J.
    Burr, David B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (10) : 1689 - 1697
  • [40] Compliance after switching from branded to generic statins
    Romanelli, Robert J.
    Jukes, Trevor
    Segal, Jodi B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (10) : 1093 - 1100
12345